Won-ji Ryu

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Impact of germline RAD51D mutations on breast cancer: Susceptibility to DNA-damaging agents.

Impact of germline RAD51D mutations on breast cancer: Susceptibility to DNA-damaging agents.

Journal: Molecular therapy. Oncology

Published: November 05, 2025

Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer.

Proteogenomic decoding of chemotherapy resistance in patients with triple-negative breast cancer.

Journal: Genome biology

Published: August 08, 2025

Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation.

Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation.

Journal: Experimental & molecular medicine

Published: January 05, 2023

Pyruvate Kinase M2 Promotes Hair Regeneration by Connecting Metabolic and Wnt/β-Catenin Signaling.

Pyruvate Kinase M2 Promotes Hair Regeneration by Connecting Metabolic and Wnt/β-Catenin Signaling.

Journal: Pharmaceutics

Published: November 11, 2022

Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer.

Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer.

Journal: Journal of the National Cancer Institute

Published: October 27, 2022

Structural optimization of novel Ras modulator for treatment of Colorectal cancer by promoting β-catenin and Ras degradation.

Structural optimization of novel Ras modulator for treatment of Colorectal cancer by promoting β-catenin and Ras degradation.

Journal: Bioorganic chemistry

Published: August 26, 2022

On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates.

On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates.

Journal: Breast cancer research : BCR

Published: July 12, 2022

Lipid raft protein flotillin-1 is important for the interaction between SOS1 and H-Ras/K-Ras, leading to Ras activation.

Lipid raft protein flotillin-1 is important for the interaction between SOS1 and H-Ras/K-Ras, leading to Ras activation.

Journal: International journal of cancer

Published: June 28, 2022

Molecular Characterization of BRCA1 c.5339T>C Missense Mutation in DNA Damage Response of Triple-Negative Breast Cancer

Molecular Characterization of BRCA1 c.5339T>C Missense Mutation in DNA Damage Response of Triple-Negative Breast Cancer

Journal: Cancers

Published: April 06, 2022

Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer.

Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 30, 2021

Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic cancer.

Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic cancer.

Journal: Biochemical and biophysical research communications

Published: January 24, 2021

Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer.

Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer.

Journal: Experimental & molecular medicine

Published: March 03, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026